Akanda Corp. (AKAN) |
|
0.59 -0.023 (-3.8%)
|
09-21 12:22 |
|
Open: |
0.601 |
Pre. Close: |
0.6133 |
|
High:
|
0.63 |
Low:
|
0.57 |
|
Volume:
|
120,940 |
Market Cap:
|
2(M) |
|
|
|
Technical analysis |
as of: 2023-09-21 12:14:39 PM |
|
Short-term rate:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 0.95 One year: 1.22 |
| Support: |
Support1: 0.43 Support2: 0.36 |
| Resistance: |
Resistance1: 0.81 Resistance2: 1.04 |
| Pivot: |
0.68 |
| Moving Average: |
MA(5): 0.68  MA(20): 0.63
MA(100): 0.72 MA(250): 1.54 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 22.2 %D(3): 35.5 |
| RSI: |
RSI(14): 45.1 |
| 52-week: |
High: 6.34 Low: 0.43 |
| Average Vol(K): |
3-Month: 431 (K) 10-Days: 959 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AKAN ] has closed above bottom band by 26.8%. Bollinger Bands are 77.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.69 - 0.7 |
0.7 - 0.7 |
|
Low:
|
0.57 - 0.58 |
0.58 - 0.58 |
|
Close:
|
0.59 - 0.6 |
0.6 - 0.61 |
|
Company Description |
|
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom. |
Headline News |
Wed, 20 Sep 2023
Akanda announces signing of option to develop Canadian THC and ... - Seeking Alpha
Wed, 20 Sep 2023
Akanda Corp. Announces Signing of Option to Develop Canadian ... - Business Wire
Thu, 06 Jul 2023
Akanda Corp. Receives Nasdaq Notification Regarding Minimum ... - Business Wire
Mon, 29 May 2023
Akanda Corp. Announces Termination of Loan Agreement - Business Wire
Wed, 03 May 2023
Why Is Akanda (AKAN) Stock Up 114% Today? - InvestorPlace
Fri, 28 Apr 2023
Akanda Corp. Announces Loan Agreement - Business Wire
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
4 (M) |
| Shares Float |
2 (M) |
|
% Held by Insiders
|
24.4 (%) |
|
% Held by Institutions
|
0.2 (%) |
|
Shares Short
|
126 (K) |
|
Shares Short P.Month
|
3 (K) |
Stock Financials |
|
EPS
|
-3.42 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
7.76 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-760.7 |
|
Return on Assets (ttm)
|
-53 |
|
Return on Equity (ttm)
|
-66.7 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0.84 |
|
Sales Per Share
|
0.67 |
|
EBITDA (p.s.)
|
-4.24 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-11 (M) |
|
Levered Free Cash Flow
|
-2 (M) |
Stock Valuations |
|
PE Ratio
|
-0.17 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.07 |
|
Price to Sales
|
0.84 |
|
Price to Cash Flow
|
-0.2 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
